Researchers say cells that are involved in fighting infections may also be the cause of high blood pressure after a period of psychological stress.
The findings suggest that the effects of chronic stress on cardiovascular health may be a side effect of having an immune system that can defend us from infection.
The results also have potential implications for treating both high blood pressure and anxiety disorders.
"Our goal was to examine the role of T cells in stress-dependent hypertension."
In the current study, researchers subjected mice to psychological stress by confining them in a small space for one hour and then putting them in cages where other mice had already left their scents.
Two hours of stress per day, for a week, results in a short-term rise in systolic blood pressure in normal mice.
However, mice that were genetically engineered to lack T cells did not display an increase in blood pressure under the same regimen. Introducing T cells into mice that lacked them made their blood pressure sensitive to stress again.
Harrison and his colleagues had previously shown that T cells are needed for the increase in blood pressure coming from high dietary salt or the hormone angiotensin, which regulates blood pressure, and continue to investigate the role of T cells in high blood pressure.
Several studies in animals have suggested that medications now used to control blood pressure, such as angiotensin receptor blockers or ACE (angiotensin converting enzyme) inhibitors, may also be helpful in the reduction of stress and anxiety, Marvar said.
"Further understanding the mechanisms underlying these observations and determining whether they may benefit people with anxiety disorders, for example post-traumatic stress disorder (PTSD), is a current goal of my research," he said.
High blood pressure is a risk factor for heart attack and stroke, and many people take medications to reduce their blood pressure. Yet some find that medications are not effective in controlling their blood pressure, and researchers are investigating various alternative approaches.
"There are still many unanswered questions about clinical relevance and safety in treating hypertensive patients by targeting the immune system," Marvar said.
"Understanding what triggers the immune response in hypertension will ultimately guide the feasibility of future clinical applications," Marvar added.
The study has been published in the journal Biological Psychiatry.